FDA label expansion for UCB’s Cimzia
The FDA has approved the drug for a certain type of inflammatory arthritis called non-radiographic axial spondyloarthritis.
Read More
Tag: inflammatory arthritis
- Ipsen announces new data on Dysport in neurological disease
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Cellistic launches new iPSC-based platforms to expand immuno-oncology therapies
